The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas

Oncogene

Volumn 18, Issue 30, 1999, Pages 4388-4393

  Klugbauer, S ^a   Rabes, H M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chernobyl; Dimerization domain; New RET rearrangements; RT PCR, transcriptional regulatory proteins

Indexed keywords

CELL NUCLEUS RECEPTOR; HYBRID PROTEIN; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER RISK; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL DIFFERENTIATION; CELL MATURATION; CHERNOBYL ACCIDENT; CHILDHOOD CANCER; DNA FINGERPRINTING; FEMALE; FUSION GENE; GENE ACTIVATION; GENE EXPRESSION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; NUCLEOTIDE SEQUENCE; PAPILLOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; THYROID CARCINOMA;

ACCIDENTS, RADIATION; AMINO ACID SEQUENCE; BLOTTING, NORTHERN; BYELARUS; CARCINOMA, PAPILLARY; CHILD, PRESCHOOL; DROSOPHILA PROTEINS; FEMALE; GENE REARRANGEMENT; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS, RADIATION-INDUCED; NUCLEAR PROTEINS; POWER PLANTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE HOMOLOGY, AMINO ACID; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; UKRAINE;

EID: 0033615042     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202824     Document Type: Article

References (35)

1. Alen P, et al. (1999). Mol. Endocrinol., 13, 117-128.
2. Altshul SF, et al. (1990). J. Mol. Biol., 215, 403-410.
3. Avantaggiato V, et al. (1994). Cell Growth Diff., 5, 305-311.
4. Baverstock K, et al. (1992). Nature, 359, 21-22.
5. Bongarzone I, et al. (1993). Mol. Cell. Biol., 13, 358-366.
6. Bongarzone I, et al. (1994). Cancer Res., 54, 2979-2985.
7. De Vita G, et al. (1998). Cell Growth Differ., 9, 97-103.
8. Durbec P, et al. (1996). Nature, 381, 789-793.
9. Feng DF and Doolittle RF. (1987). J. Mol. Evol., 25, 351-360.
10. Fugazzola L, et al. (1995). Cancer Res., 55, 5617-5620.
11. Fugazzola L, et al. (1996). Oncogene, 13, 1093-1097.
12. Grieco M, et al. (1990). Cell, 60, 557-663.
13. Jeanmougin F, et al. (1997). TIBS, 22, 151-153.
14. Jhiang SM, Smanik PA and Mazzaferri EL. (1994). Cancer Lett., 78, 69-76.
15. Jing S, et al. (1996). Cell, 85, 1113-1124.
16. Kazakov VS, Demidchik EP and Astakhova LN. (1992). Nature, 359, 21-22.
17. Klugbauer S, Lengfelder E, Demidchik EP and Rabes HM. (1995). Oncogene, 11, 2459-2467.
18. Klugbauer S, Lengfelder E, Demidchik EP and Rabes HM. (1996). Oncogene, 13, 1099-1102.
19. Klugbauer S, Demidchik EP, Lengfelder E and Rabes HM. (1998a). Oncogene, 16, 671-675.
20. Klugbauer S, Demidchik EP, Lengfelder E and Rabes HM. (1998b). Cancer Res., 58, 198-203.
21. Kunieda T, Matsui M, Nomura N and Ishizaki R, (1991). Gene, 107, 323-328.
22. Le Douarin B, et al. (1995). EMBO J., 14, 2020-2033.
23. Le Douarin B, et al. (1996). EMBO J., 15, 6701-6715.
24. Lehrach H, et al. (1990). In: Genome Analysis Volume 1: Genetic and Physical Mapping. Davies KE and Tilghman SM. (eds). Cold Spring Harbor Laboratory Press: Cold Spring Harbor, pp. 39-81.
25. Nikiforov Y and Gnepp DR. (1994). Cancer, 74, 748-766.
26. Nikiforov YE, et al. (1997). Cancer Res., 57, 1690-1694.
27. Rabes HM and Klugbauer S. (1997). Verh. Dtsch. Ges. Path., 81, 139-144.
28. Rabes HM and Klugbauer S. (1998). Rec. Res. Cancer Res., 154, 149-165.
29. Sagartz JE, Jhiang SM, Tong Q and Capen CC. (1997). Lab. Invest., 76, 307-318.
30. Takahashi M, Inaguma Y, Hiai H and Hirose F. (1988). Mol. Cell. Biol., 8, 1853-1856.
31. Thénot S, Henriquet C, Rochefort H and Cavailles V. (1997). J. Biol. Chem., 272, 12062-12068.
32. Tong Q, Xing S and Jhiang SJ. (1997). J. Biol. Chem., 272, 9043-9047.
33. Trupp M, et al. (1996). Nature, 381, 785-789.
34. Xing S, Furminger TL, Tong Q and Jhiang SM. (1998). J. Biol. Chem., 273, 4909-4914.
35. Yeh S and Chang C. (1996). Proc. Natl. Acad. Sci. USA, 93, 5517-5521.